[1]
F. Stenmark, L. Brudin, H. Kjölhede, R. Peeker, and J. Stranne, “Treatment with CoreTherm in 570 patients with prostate volumes of 80-366 ml: an evaluation of short- and long-term retreatment risk”, SJU, vol. 56, no. 4, pp. 336–341, Jul. 2022.